Targeting a cancer's blood supply
All cancers need to develop their own blood supply in order to keep growing. Professor Adrian Harris' research group based at the Weatherall Institute for Molecular Medicine is studying this process of new blood vessel growth, called angiogenesis, in great detail.
Using this knowledge, they are developing ways to block angiogenesis and starve cancer cells of essential nutrients and oxygen. Professor Harris is a leading researcher in this field and is also running clinical trials to study new anti-angiogenesis drugs in people with cancer.
Listen to a short interview with Professor Harris about his research:
Other research projects by Adrian Harris
Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer
Clin Cancer Res.2011;17 :372-381
Human endothelial stem/progenitor cells, angiogenic factors and vascular repair
J R Soc Interface.2010;7 :S731-S751